TALOS ENERGY INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TALOS ENERGY INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.78B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.97B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.46B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.65B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.24B | Nov 12, 2024 |
| FY2020 | Dec 31, 2020 | $175.71M | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | $135.14M | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | $88.87M | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $187.76M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $233.24M | Mar 11, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($494.29M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($76.39M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $187.33M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $381.92M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($182.95M) | Nov 12, 2024 |
| FY2020 | Dec 31, 2020 | ($430.74M) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | ($52.00M) | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | ($140.61M) | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | $157.75M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $304.0K | Mar 11, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($560.28M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $172.93M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $209.79M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $736.12M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $374.62M | Nov 12, 2024 |
| FY2020 | Dec 31, 2020 | ($285.44M) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | ($37.06M) | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | ($94.60M) | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | ($4.21M) | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $46.97M | Mar 11, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $935.83M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $962.59M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $519.07M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $709.74M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $411.39M | Nov 12, 2024 |
| FY2022 | Dec 31, 2020 | $301.92M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $393.73M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $263.45M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $176.05M | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $116.12M | Mar 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.55B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $6.19B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $4.82B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $3.06B | Nov 12, 2024 |
| FY2022 | Dec 31, 2021 | $2.77B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.83B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.59B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $2.48B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.24B | Mar 13, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.38B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $3.43B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.66B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.89B | Nov 12, 2024 |
| FY2022 | Dec 31, 2021 | $2.01B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.91B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.51B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.47B | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $1.29B | Mar 13, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.76B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.16B | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | $1.17B | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | $760.65M | Feb 27, 2025 |
| FY2023 | Dec 31, 2020 | $926.60M | Nov 12, 2024 |
| FY2022 | Dec 31, 2019 | $1.08B | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $1.01B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | ($54.09M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2016 | $6.99M | Mar 12, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($918.40M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | ($424.11M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | ($347.72M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($535.05M) | Nov 12, 2024 |
| FY2022 | Dec 31, 2021 | ($916.96M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($734.01M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($268.41M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($327.14M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($548.35M) | Mar 13, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $362.81M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $108.17M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $33.64M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $44.15M | Nov 12, 2024 |
| FY2022 | Dec 31, 2021 | $69.85M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $34.23M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $87.02M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $139.91M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $32.19M | Mar 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $1.03B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $585.34M | Nov 12, 2024 |
| FY2022 | Dec 31, 2021 | $962.73M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $985.51M | Feb 25, 2022 |
| FY2018 | Dec 31, 2017 | $402.06M | Mar 13, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Nov 12, 2024 |
| FY2020 | Dec 31, 2020 | (5) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | (2) | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (2) | Nov 12, 2024 |
| FY2020 | Dec 31, 2020 | (5) | Mar 11, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 11, 2021 |
| FY2020 | Jun 30, 2020 | (2) | Mar 11, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 11, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 82.57M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 81.88M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 81.28M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 54.20M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 54.16M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | 31.24M | Mar 13, 2019 |